Healthcare Sector

Members of Parliament invested in the Healthcare Sector

152 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£142.73	230.09%	£231,061.50
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£142.73	209.41%	£216,585.72
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£11,396.00	-5.22%	£66,343.98
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£11,396.00	176.87%	£193,809.52
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£11,396.00	193.98%	£205,783.57
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£11,396.00	53.54%	£107,480.46
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£11,396.00	-3.21%	£67,752.68
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£11,396.00	327.38%	£299,163.70
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£11,396.00	-6.25%	£65,623.56
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£11,396.00	110.37%	£147,262.32
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£11,396.00	-4.43%	£66,900.37
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£11,396.00	11.40%	£77,978.49
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£11,396.00	42.36%	£99,652.72
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£11,396.00	287.88%	£271,518.04
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£2.12	-35.95%	£44,833.83
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£40.36	7.94%	£75,560.31
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£40.36	-24.46%	£52,876.66
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£40.36	-5.66%	£66,040.21
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£40.36	2.49%	£71,742.00
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£40.36	-4.61%	£66,773.81
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£40.36	2.20%	£71,542.16
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£40.36	-9.81%	£63,132.96
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£40.36	-8.31%	£64,179.92
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£40.36	8.00%	£75,600.75
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£177.20	7.37%	£75,162.09
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£177.20	44.49%	£101,141.55
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£177.20	143.77%	£170,642.45
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£177.20	190.83%	£203,577.87
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£177.20	9.57%	£76,700.47
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£192.94	112.16%	£148,513.78
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£192.94	167.40%	£187,179.53
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£192.94	-22.48%	£54,265.66
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£273.10	116.57%	£151,601.91
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£341.61	34.91%	£94,434.48
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£341.61	-30.29%	£48,795.45
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£341.61	-36.48%	£44,461.44
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£341.61	-34.08%	£46,145.69
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£341.61	-42.53%	£40,229.98
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,273.96	89.44%	£132,607.47
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£472.64	13.03%	£79,123.74
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£472.64	2.92%	£72,042.51
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£472.64	-19.02%	£56,687.00
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£472.64	2.07%	£71,451.28
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£472.64	-1.00%	£69,300.60
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£162.30	-73.51%	£18,545.54
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£162.30	-49.28%	£35,503.13
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£58.20	60.11%	£112,077.04
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£58.20	-42.77%	£40,062.94
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£58.20	-52.59%	£33,189.41
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£58.20	-56.78%	£30,253.97
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£146.93	-12.59%	£61,184.41
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£146.93	-9.76%	£63,168.52
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£122.47	38.57%	£97,000.46
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£122.47	85.42%	£129,797.27
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£122.47	126.62%	£158,636.32
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£208.00	-8.57%	£64,000.00
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£260.40	3.39%	£72,376.41
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£260.40	-15.91%	£58,866.46
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£260.40	1.80%	£71,258.79
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£260.40	-14.06%	£60,158.41
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£134.17	431.02%	£371,716.94
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£134.17	23.30%	£86,306.74
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£134.17	307.81%	£285,468.06
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£15.07	-85.11%	£10,423.91
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£24.05	23.05%	£86,136.36
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£24.05	-17.13%	£58,006.18
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£37.31	65.05%	£115,536.18
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£37.31	77.83%	£124,482.90
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£303.68	248.70%	£244,087.73
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£376.88	442.90%	£380,028.83
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£376.88	37.05%	£95,933.09
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£35.75	-25.21%	£52,353.56
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£35.75	-34.94%	£45,541.40
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£6.21	-51.52%	£33,934.43
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£74.00	-6.85%	£65,206.44
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£74.00	40.52%	£98,366.88
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£27.38	-71.26%	£20,119.67
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£129.44	-52.72%	£33,098.81
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£220.81	37.31%	£96,117.78
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£433.66	56.08%	£109,253.91
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£433.66	23.62%	£86,536.67
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£4.61	32.47%	£92,729.89
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.00	-100.00%	£0.33
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£399.39	1,187.52%	£901,266.96
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£30.30	21.15%	£84,805.39
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,520.00	-5.90%	£65,870.05
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£640.86	2,039.05%	£1,497,336.46
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£760.13	3.94%	£72,756.62
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,627.00	-19.69%	£56,214.22
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£4.09	-90.55%	£6,613.54
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£650.90	16.86%	£81,800.72
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£4.84	245.71%	£242,000.01
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.05	88.50%	£131,951.88
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.64	-48.95%	£35,736.33
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£3.44	79.17%	£125,416.67
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£1.61	54.81%	£108,365.39
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£32.04	112.89%	£149,023.26
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.08	-94.49%	£3,857.14
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.86	-92.87%	£4,987.50
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£4.09	-61.49%	£26,958.57
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£5.80	-48.44%	£36,088.89
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£35.64	18.48%	£82,938.83
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£25.00	-77.67%	£15,627.79
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£341.90	1.73%	£71,207.97
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£11.50	-9.09%	£63,636.36
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£270.20	30.22%	£91,151.81
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£270.20	-1.10%	£69,231.33
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.75	-97.12%	£2,019.23
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£52.00	-53.57%	£32,500.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£52.00	0.97%	£70,679.61
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£76.42	337.44%	£306,204.93
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.25	-89.17%	£7,583.33
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£2.58	-34.68%	£45,721.52

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.